Blood glucose concentrations ≤125 mg/dl and coronary heart disease risk

      This study sought to determine the relation between fasting glucose levels, coronary heart disease (CHD) risk factors, and the prevalence of CHD in a high-risk group of patients attending a cardiology prevention clinic. The study was designed to address 2 questions. (1) Are increasing fasting glucose concentrations in the nondiabetic range (≤125 mg/dl) associated with an increased burden of traditional (smoking, central obesity, systemic hypertension, dyslipidemia) and nontraditional (e.g., fibrinogen, homocysteine, lipoprotein(a) [Lp(a)]) CHD risk factors? (2) Are increasing blood glucose concentrations in this range associated with a continuous and graded risk for CHD independent of these risk factors?
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus.
        Diabetes Care. 2000; 23: S4-S19
        • Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure
        The sixth report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNCVI).
        Arch Intern Med. 1997; 157: 2413-2446
        • Programs L.R.C
        Manual of Laboratory Operations, Lipid and Lipoprotein Analysis.
        in: Hainline A Karon J Lippel K HEW Publication no. (NIH) 75–628 (revised). National Heart, Lung and Blood Institute (US Government Printing Office No. 1982–361–132, Bethesda, MD1982: 678
        • Jacobsen D.W
        • Gatautis V.J
        • Green R
        • Robinson K
        • Savon S.R
        • Secic M
        • Ji J
        • Otto J.M
        • Taylor Jr, L.M
        Rapid HPLC determination of total homocysteine and other thiols in serum and plasma.
        Clin Chem. 1994; 40: 873-881
        • Sweetnam P.M
        • Yarnell J.W
        • Lowe G.D
        • Baker I.A
        • O’Brien J.R
        • Rumley A
        • Etherington M.D
        • Whitehead P.J
        • Elwood P.C
        The relative power of heat-precipitation nephelometric and clottable (Clauss) fibrinogen in the prediction ofischaemic heart disease.
        Br J Haematol. 1998; 100: 582-588
        • Hosmer D
        • Lemeshow S
        Assessing the fit of the model.
        in: In: Applied Logistic Regression. John Wiley & Sons, New York1989: 140-145
        • Meigs J.B
        • Nathan D.M
        • Wilson P.W
        • Cupples L.A
        • Singer D.E
        Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance. The Framingham Offspring Study.
        Ann Intern Med. 1998; 128: 524-533
        • Bjornholt J.V
        • Erikssen G
        • Aaser E
        • Sandvik L
        • Nitter-Hauge S
        • Jervell J
        • Erikssen J
        • Thaulow E
        Fasting blood glucose.
        Diabetes Care. 1999; 22: 45-49
        • Balkare B
        • Bertrais S
        • Ducimetiere P
        • Eschwege E
        Is there a glycemic threshold for mortality risk?.
        Diabetes Care. 1999; 22: 696-699
        • Gerstein H
        Is glucose a continuous risk factor for cardiovascular mortality?.
        Diabetes Care. 1999; 22 ([editorial]): 659-660
        • Gerstein H.C
        • Pais P
        • Pogue J
        • Yusuf S
        Relationship of glucose and insulin levels to the risk of myocardial infarction.
        J Am Coll Cardiol. 1999; 33: 612-619
        • Singh J.P
        • Larson M.G
        • O’Donnell C.J
        • Wilson P.F
        • Tsuji H
        • Lloyd-Jones D.M
        • Levy D
        Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study).
        Am J Cardiol. 2000; 86: 309-312
        • DECODE Study Group, the European Diabetes Epidemiology Group
        Glucose tolerance and cardiovascular mortality.
        Arch Intern Med. 2001; 161: 397-405
        • Coutinho M
        • Gerstein H
        • Wang Y
        • Yusuf S
        The relationship between glucose and incident cardiovascular events.
        Diabetes Care. 1999; 22: 233-240